chr22-30695175-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030758.4(OSBP2):āc.266A>Gā(p.Glu89Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,611,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030758.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBP2 | NM_030758.4 | c.266A>G | p.Glu89Gly | missense_variant | 1/14 | ENST00000332585.11 | NP_110385.1 | |
OSBP2 | NM_001282739.2 | c.266A>G | p.Glu89Gly | missense_variant | 1/14 | NP_001269668.1 | ||
OSBP2 | NM_001282738.2 | c.149+831A>G | intron_variant | NP_001269667.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBP2 | ENST00000332585.11 | c.266A>G | p.Glu89Gly | missense_variant | 1/14 | 1 | NM_030758.4 | ENSP00000332576.6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000810 AC: 2AN: 246768Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134166
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459732Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 725906
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.266A>G (p.E89G) alteration is located in exon 1 (coding exon 1) of the OSBP2 gene. This alteration results from a A to G substitution at nucleotide position 266, causing the glutamic acid (E) at amino acid position 89 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at